Compare MGTX & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGTX | FRGE |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 665.7M | 615.4M |
| IPO Year | N/A | N/A |
| Metric | MGTX | FRGE |
|---|---|---|
| Price | $8.20 | $44.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | $23.83 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 620.5K | 279.6K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $27,417,000.00 | ★ $92,884,000.00 |
| Revenue This Year | N/A | $33.10 |
| Revenue Next Year | $619.95 | $24.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 96.83 | 16.40 |
| 52 Week Low | $4.55 | $6.60 |
| 52 Week High | $9.73 | $44.76 |
| Indicator | MGTX | FRGE |
|---|---|---|
| Relative Strength Index (RSI) | 51.70 | 81.50 |
| Support Level | $7.84 | $44.27 |
| Resistance Level | $8.53 | $44.75 |
| Average True Range (ATR) | 0.55 | 0.17 |
| MACD | -0.03 | -0.65 |
| Stochastic Oscillator | 35.84 | 93.75 |
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.